Assessing and measuring nonresponse in schizophrenia.
Symptom resolution, relapse prevention, and recovery of function are the goals of schizophrenia treatment. Often, clinicians rely on clinical impressions and informal interviews to judge whether treatment strategies are achieving these goals. However, measurement-based rating scales can assist clinicians in diagnosing patients, as well as in assessing their treatment response, evaluating the tolerability of adverse effects, and documenting the efficacy of treatment trials. Evaluating early treatment response or nonresponse can help clinicians in formulating long-term strategies to help patients achieve optimal outcomes.
Department of Neurology, Albert Einstein College of Medicine of Yeshiva University, NY, USA.
John M
JM
Kane
D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004351:Drug Resistance; D006801:Humans; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000175:diagnosis* / Q000188:drug therapy*
D014150:Antipsychotic Agents